Tag: TSXV:ACST

October 10, 2019

3 Top Pharma Stocks on the TSX and TSXV Year-to-Date

With three quarters of the year over, it's time to look back on the top-performing pharma stocks on the TSX...
September 30, 2019

Acasti Pharma Releases Additional Phase 3 Milestones

The company said that almost 80 percent of the patients in the Phase 3 TRILOGY trial have completed randomization in...
September 9, 2019

Acasti Pharma Receives Funding from the Government of Canada

Acasti Pharma (NASDAQ:ACST, TSXV:ACST) has announced the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) has awarded it...
December 31, 2018

Acasti Pharma Announces Data on TRILOGY Phase 3 Trials of CaPre in Patients

Acasti Pharma (NASDAQ:ACST;TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3...
November 14, 2018

Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019

Acasti Pharma (NASDAQ:ACST,TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid)...
October 4, 2018

Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares

Acasti Pharma (NASDAQ:ACST;TSXV:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3...